4-phenylenediamine has been researched along with Chronic Primary Open Angle Glaucoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abernathy, E; Alt, C; Arora, P; Bloch, KD; Brouckaert, P; Buys, ES; Clerté, M; de Waard, N; Giani, A; Gong, H; Gregory, MS; Hayton, SR; Jones, A; Kang, JH; Ko, YC; Ksander, BR; Lin, CP; Loomis, SJ; Malhotra, R; Nathan, D; Oh, DJ; Pasquale, LR; Ren, R; Rhee, DJ; Scherrer-Crosbie, M; Tainsh, LT; Tainsh, RE; Turcotte, R; Wiggs, JL; Yu, B | 1 |
1 other study(ies) available for 4-phenylenediamine and Chronic Primary Open Angle Glaucoma
Article | Year |
---|---|
Soluble guanylate cyclase α1-deficient mice: a novel murine model for primary open angle glaucoma.
Topics: Analysis of Variance; Animals; Disease Models, Animal; Female; Glaucoma, Open-Angle; Guanylate Cyclase; Immunohistochemistry; Intraocular Pressure; Mice; Mice, Knockout; Mice, Mutant Strains; Ophthalmoscopy; Optic Nerve; Phenylenediamines; Receptors, Cytoplasmic and Nuclear; Retinal Neurons; Soluble Guanylyl Cyclase; Tomography, Optical Coherence | 2013 |